Clinical trials
Recruiting Fatty Liver trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| University of Oxford | 2 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Newcastle University | 1 |
| Novo Nordisk A/S | 1 |
| Queen Mary University of London | 1 |
| Richmond Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 11 |
| Non-alcoholic Fatty Liver Disease | 6 |
| Fibrosis | 3 |
| Obesity | 3 |
| Digestive System Diseases | 2 |
| Liver Diseases | 2 |
| Metabolic Diseases | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.